Debt-to-equity in % of INTERCEPT PHARMACEUTICALS, INC. from Q2 2013 to Q3 2023

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
INTERCEPT PHARMACEUTICALS, INC. quarterly Debt-to-equity history and change rate from Q2 2013 to Q3 2023.
  • INTERCEPT PHARMACEUTICALS, INC. Debt-to-equity for the quarter ending 30 Sep 2023 was 546 %.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

INTERCEPT PHARMACEUTICALS, INC. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2023 546 +901 30 Sep 2023
Q2 2023 527 +816 30 Jun 2023
Q1 2023 -2.18K -1.85K -566% 31 Mar 2023
Q4 2022 -491 -109 -28.7% 31 Dec 2022
Q3 2022 -355 +40.3 +10.2% 30 Sep 2022
Q2 2022 -290 +127 +30.4% 30 Jun 2022
Q1 2022 -327 +177 +35.2% 31 Mar 2022
Q4 2021 -382 +320 +45.6% 31 Dec 2021
Q3 2021 -396 +1.08K +73.2% 30 Sep 2021
Q2 2021 -416 -4.47K -110% 30 Jun 2021
Q1 2021 -504 -1.36K -159% 31 Mar 2021
Q4 2020 -702 -1.54K -183% 31 Dec 2020
Q3 2020 -1.48K -2.34K -271% 30 Sep 2020
Q2 2020 4.05K +3.15K +349% 30 Jun 2020
Q1 2020 852 -69.5 -7.55% 31 Mar 2020
Q4 2019 842 -45.3 -5.1% 31 Dec 2019
Q3 2019 864 -24.3 -2.73% 30 Sep 2019
Q2 2019 903 +83.5 +10.2% 30 Jun 2019
Q1 2019 921 +185 +25% 31 Mar 2019
Q4 2018 887 +554 +166% 31 Dec 2018
Q3 2018 888 +679 +325% 30 Sep 2018
Q2 2018 819 +670 +451% 30 Jun 2018
Q1 2018 737 +639 +653% 31 Mar 2018
Q4 2017 333 +270 +426% 31 Dec 2017
Q3 2017 209 +174 +505% 30 Sep 2017
Q2 2017 149 +135 +966% 30 Jun 2017
Q1 2017 97.9 +88.7 +967% 31 Mar 2017
Q4 2016 63.3 +57 +918% 31 Dec 2016
Q3 2016 34.5 +28.7 +489% 30 Sep 2016
Q2 2016 14 +7.45 +114% 30 Jun 2016
Q1 2016 9.17 +1.12 +13.9% 31 Mar 2016
Q4 2015 6.22 -51.8 -89.3% 31 Dec 2015
Q3 2015 5.86 -79.5 -93.1% 30 Sep 2015
Q2 2015 6.51 -140 -95.5% 30 Jun 2015
Q1 2015 8.05 -344 -97.7% 31 Mar 2015
Q4 2014 58.1 -7.24 -11.1% 31 Dec 2014
Q3 2014 85.3 +23.3 +37.6% 30 Sep 2014
Q2 2014 146 +83.4 +133% 30 Jun 2014
Q1 2014 353 31 Mar 2014
Q4 2013 65.3 31 Dec 2013
Q3 2013 62 30 Sep 2013
Q2 2013 62.7 30 Jun 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.